Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

AstraZeneca plc, BP plc and Unilever plc are Brexit dividend WINNERS

AstraZeneca plc (LON: AZN), BP plc (LON: BP) and Unilever plc (LON: ULVR) are proving a handy foxhole amid a barrage of Brexit bad news, says Harvey Jones.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Not every company stock collapsed in the aftermath of the shock Brexit referendum result, canny investors spotted opportunities as well as threats to their portfolio. As the pound collapsed, income seekers realised that companies with strong overseas earnings should prove more rewarding. Here are three stocks that are likely to be Brexit dividend winners.

Astra shines

Pharmaceuticals giant AstraZeneca (LSE: AZN) ended Friday 3.41% higher and is up 10.36% across the last turbulent week. Over the same period, sterling has fallen from around $1.46 to $1.33, a drop of around 9%. That is far from a coincidence. AstraZeneca generate more than 90% of its profits overseas but has a large cost base in the UK, which will be less of a burden as its overseas earnings rise relative to the pound.

AstraZeneca converts its dividends into pence on the day results are announced – twice a year in March and September – and although we don’t know whether the dollar will remain strong against sterling over the longer term, that’s certainly the way to bet right now. The company suffered during recent sterling strength, with Q1 results showing revenue up 5% to $6,115m, but just 1% at actual exchange rates. That now looks set to reverse. Trading at 13.3 times earnings it isn’t overpriced, while the yield is healthy at 4.9%. The big question is whether chief executive Pascal Soriot can replenish AstraZeneca’s drugs pipeline, but for now the dollar pipeline will be flowing.

Brexit petroleum

Friday’s result may have divided the nation but it united investors in pursuit of oil major BP (LSE: BP), whose share price rose 1.73% on the day and now stands nearly 6% higher than it did a week ago. In January, chief executive Bob Dudley warned that investment in the UK energy sector could fall if Britain voted to leave the EU. But the company put on a brave face after the result, publicly stating that “we do not currently expect it to have a significant impact on BP’s business or investments in the UK and continental Europe, nor on the location of our headquarters or our staff“. Investors are taking that at face value today.

The uncertainty has set back the oil price recovery, with Brent crude falling from over $50 to around $47 a barrel, but markets are calculating that this is only temporary. Sterling weakness is likely to last much longer and with oil priced in dollars BP’s revenues will be the beneficiary. As will income seekers, given that BP declares its dividend in dollars, and its current yield of 7.1% has just got even juicier.

Uni winner

Household goods giant Unilever (LSE: ULVR) is another instant Brexit winner rising 3.11% on the day and trading 6.72% higher over the week. Almost 60% of its revenues come from emerging markets, with dollar and euro earnings on top, which is good news when sterling is plunging against a basket of global currencies. 

Unilever reports in euros and UK investors have already benefitted from pre-referendum uncertainty: Unilever recently raised its Q1 dividend by 6% to EUR0.3201 per share, which equated to 17% in sterling terms. We can expect more of that, unless the euro comes under greater pressure as Brexit contagion spreads.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended AstraZeneca and BP. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female business analyst looking at a graph chart while working from home
Investing Articles

After Qatar cuts its stake in Sainsbury’s, is its share price now a great short-term risk/long-term reward play?

Sainsbury’s share price slid after Qatar cut its stake, but with a new activist investor at the helm, does it…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

British billionaire has 61% of his hedge fund in these 3 S&P 500 stocks 

This world-class hedge fund manager only invests in companies with extremely wide moats. Which three S&P 500 stocks currently dominate…

Read more »

Businessman hand flipping wooden block cube from 2024 to 2025 on coins
Investing Articles

I’m targeting £11,363 a year in retirement from £20,000 in Aviva shares!

£20,000 invested in Aviva shares could make me £11,363 in annual retirement income from this FTSE 100 passive income investment…

Read more »

Investing Articles

Down 20% but 15% annual earnings growth forecast — is BT’s share price a bargain or a bust going into 2026?

BT’s share price has fallen a long way since July, but analysts forecast strong earnings growth in the coming years,…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

I asked ChatGPT to produce an unbeatable second income ISA portfolio and it said… 

Harvey Jones asked artificial intelligence to come up with a portfolio of dividend-paying stocks to produce a second income for…

Read more »

Investing Articles

Worried about a 2026 stock market slump? This ISA investment pays 4%+ with low risk

This type of low-risk fund could be an option to consider for ISA investors who are waiting for better stock…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

2 British income shares to consider before the Christmas boom

Our writer scoured historical market data to uncover which income shares typically do well in the run up to Christmas.…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Will Rolls-Royce shares continue their epic run into 2026 and beyond?

Noting that differences of opinion make the world go round, James Beard discusses what might happen to Rolls-Royce’s shares next…

Read more »